This study applied nasal transcriptomics to characterize molecular asthma endotypes and their clinical correlates in a cohort of U.S. Hispanic adults. The SOL‑Asthma cohort included 313 adults with asthma (cases) and 371 without asthma (controls) drawn from Puerto Rican and Dominican participants living in the Bronx, NY and Chicago, IL. Selected findings were tested for replication in 376 adults of African ancestry from the CAAPA cohort.
The primary aim was to identify transcriptomic profiles based on nasal expression of predefined signature genes for T helper cell pathways and to assess associations between those profiles and demographic variables, clinical characteristics, and severe asthma exacerbations (SAEs).
Investigators profiled nasal RNA and evaluated expression of sets of “signature genes” representing three immunologic pathways: three T2 pathway signatures, five T1 pathway signatures, and five T17 pathway signatures. The authors used these pathway signatures to classify subjects into transcriptomic profiles (endotypes). Multinomial logistic regression was used to analyze profile membership with controls as the reference category. Analyses included cross‑sectional assessment at baseline and longitudinal evaluation of SAEs over a one‑year follow‑up period.
Five distinct transcriptomic profiles were identified among asthma cases using nasal gene expression:
These profiles reflect relative enrichment of signature genes for the respective T helper pathways and include a T2LOW group characterized by low expression across T2, T1, and T17 signatures.
Multivariable analyses examined associations between participant characteristics and transcriptomic profile membership. Key reported associations included:
Puerto Rican background (versus Dominican) was associated with higher odds of the T17HIGH profile (odds ratio [OR]=2.48, 95% confidence interval [CI]=1.08–5.74).
Female sex was associated with increased odds of the T1HIGH profile (OR=3.44, 95% CI=1.33–8.88) and with the T1HIGH/T17HIGH and T2LOW/T1LOW/T17LOW profiles.
Physician‑diagnosed chronic obstructive pulmonary disease (COPD) was associated with profiles other than T2HIGH or T1HIGH.
These findings indicate demographic and comorbid condition correlates of non‑T2 (T2LOW) molecular profiles in this Hispanic adult population.
The study assessed associations between molecular profiles and severe asthma exacerbations (SAEs). The T1HIGH profile was associated with having at least one SAE in the year prior to baseline and with SAEs during the subsequent one‑year follow‑up (reported OR=4.31, 95% CI=1.26–14.77). The manuscript links the T1HIGH endotype to increased risk of exacerbations compared with controls and some other profiles.
Each transcriptomic profile exhibited a set of unique differentially expressed genes (DEGs). The authors report substantial replication of both the distribution of profiles and many profile‑specific DEGs in the independent CAAPA cohort of adults of African ancestry, supporting external consistency of molecular patterns identified in nasal samples.
The analyses combined cross‑sectional and longitudinal approaches. The primary outcome was transcriptomic endotype defined by nasal expression of signature genes; secondary analyses examined SAEs at baseline and over one year. The work is presented as a preprint and has not undergone peer review; the authors explicitly note it should not be used to guide clinical practice. Institutional Review Boards at the Data Coordinating Center (University of North Carolina) and at each participating center approved the study, and participants provided written informed consent. The authors state that all study data are available upon reasonable request.
The report does not include additional methodological details beyond what is summarized here (for example, exact gene lists for the signatures, sequencing platform metrics, or full statistical modeling parameters are provided in the source manuscript and supplementary materials).
Nasal transcriptomic profiling in this cohort of Puerto Rican and Dominican adults with asthma identified five molecular endotypes, including T2LOW profiles that were associated with demographic factors (Puerto Rican background, female sex) and comorbid COPD. The T1HIGH endotype showed a strong association with severe asthma exacerbations. Many findings were substantially replicated in an independent cohort. As the study is a preprint, these results represent preliminary evidence that nasal gene expression can stratify asthma heterogeneity across diverse populations; further peer‑reviewed confirmation and mechanistic follow‑up are warranted.